Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2025-12-24 @ 11:35 PM
NCT ID:
NCT00115856
Eligibility Criteria:
Inclusion Criteria:
* Male and female adults (aged 25-80) seen at the Brigham and Women's Hospital (BWH) clinic who have known arterial disease who consent to cannulation of the femoral artery for this research.
* Patients in the prespecified age group who are scheduled to undergo a clinically indicated heart or peripheral catheterization at the BWH catheterization (cath) lab who will have a tube (sheath) already positioned in their femoral artery
* Patient must be in stable condition with regard to symptoms, vital signs and the monitored electrocardiogram
Exclusion Criteria:
* Unstable symptoms, vital signs or electrocardiogram after the heart cath
* Any complications during the heart cath (eg., bleeding, angina, arrhythmias, technical difficulties cannulating the femoral artery)
* Creatinine \>2.0mg/dl
* Pregnancy
* Contraindications to anticoagulation
* Patients with a metal implant, pacemaker, cardiac defibrillator, metal fragments in the eye, bullets/metal objects in the body
Sex:
ALL
Minimum Age:
25 Years
Maximum Age:
80 Years
Study:
NCT00115856
Study Brief:
Protocol Section:
NCT00115856